The Hertford British Hospital was a hospital founded in Paris in 1871 for British and other English-speaking patients. In 2008 it merged with a nearby French hospital and was renamed to Hôpital franco-britannique.

During the past decade, Institut Hospitalier Franco-Britannique conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 1 clinical trials were completed, i.e. on average, 3% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Institut Hospitalier Franco-Britannique" #1 sponsor was "GERCOR - Multidisciplinary Oncology Cooperative Group" with 14 trials, followed by "Hopital Foch" with 8 trials sponsored, "UNICANCER" with 5 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 3 trials sponsored and "GCS IHFB Cognacq-Jay" with 3 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institut Hospitalier Franco-Britannique" #1 collaborator was "AstraZeneca" with 5 trials as a collaborator, "GERCOR - Multidisciplinary Oncology Cooperative Group" with 2 trials as a collaborator, "Hospital Ambroise Paré Paris" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Bicetre Hospital" with 1 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Institut Hospitalier Franco-Britannique" are "Metastatic Colorectal Cancer" (4 trials), "Colorectal Cancer" (3 trials), "Lung Cancer" (3 trials), "Breast Cancer" (2 trials) and "Cancer Colorectal" (2 trials). Many other conditions were trialed in "Institut Hospitalier Franco-Britannique" in a lesser frequency.

Most popular intervention types in "Institut Hospitalier Franco-Britannique" are "Drug" (31 trials), "Device" (7 trials), "Other" (4 trials), "Procedure" (4 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "fluorouracil" (4 trials), "cisplatin" (3 trials), "gemcitabine hydrochloride" (3 trials), "Irinotecan" (2 trials) and "leucovorin calcium" (2 trials). Other intervention names were less common.

The vast majority of trials in "Institut Hospitalier Franco-Britannique" are 40 trials for "All" genders, 7 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Institut Hospitalier Franco-Britannique". 1 are not yet recruiting, 15 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Institut Hospitalier Franco-Britannique, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Institut Hospitalier Franco-Britannique, 2 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 14 trials that are defined as “Not Applicable".

Institut Hospitalier Franco-Britannique has several departments that took part in Clinical trials: "Institut Hospitalier Franco-Britannique; Cancerologie" - 4 trials